Genomes and Genes


Karin Jensen


Affiliation: Karolinska Institutet
Country: Sweden


  1. Jensen K, Kirsch I, Odmalm S, Kaptchuk T, Ingvar M. Classical conditioning of analgesic and hyperalgesic pain responses without conscious awareness. Proc Natl Acad Sci U S A. 2015;112:7863-7 pubmed publisher
  2. Jensen K. What Is Minimally Required to Elicit Placebo Effects?. Int Rev Neurobiol. 2018;138:181-199 pubmed publisher
    ..Together with recent conceptualizations of placebo effects in terms of predictive coding, there is evidence to suggest that placebo effects are fundamental responses of the brain that have developed to promote survival. ..
  3. Kosek E, Martinsen S, Gerdle B, Mannerkorpi K, Löfgren M, Bileviciute Ljungar I, et al. The translocator protein gene is associated with symptom severity and cerebral pain processing in fibromyalgia. Brain Behav Immun. 2016;58:218-227 pubmed publisher
    ..Furthermore, the functional magnetic resonance findings indicated an effect of translocator protein on the affective-motivational components of pain perception. ..
  4. Kosek E, Rosén A, Carville S, Choy E, Gracely R, Marcus H, et al. Lower Placebo Responses After Long-Term Exposure to Fibromyalgia Pain. J Pain. 2017;18:835-843 pubmed publisher
    ..Long-term exposure to fibromyalgia pain was associated with lower placebo analgesia, and the results show the importance of taking pain duration into account when interpreting the results from placebo-controlled trials. ..
  5. Jensen K, Kirsch I, Pontén M, Rosén A, Yang K, Gollub R, et al. Certainty of genuine treatment increases drug responses among intellectually disabled patients. Neurology. 2017;88:1912-1918 pubmed publisher